BREAKING NEWS: Gilead’s remdesivir gets FULL FDA approval as a treatment for coronavirus patients
- On Thursday, the FDA gave full approval for the antiviral drug remdesivir as a treatment for the novel coronavirus
- Previously, it was the only medication approved in the US to treat COVID-19 patients by emergency use
- A recent NIH study found remdesivir shortened coronavirus hospital stays by five days and reduces the risk of death by 30%
The US Food and Drug Administration (FDA) has given full approval to the antiviral drug remdesivir as a coronavirus treatment.
Manufactured by California-based Gilead Sciences Inc, the medication was the only approved for emergency use in the US to treat severely ill COVID-19 patients.
According to the FDA’s website says the drug has been approved in two forms: five milligrams (mg) per milliliter dropper and 100 mg per vial.
A recent study from the National Institutes of Health found that remdesivir shortened coronavirus hospital stays by five days and reduces the risk of death by 30 percent.
On Thursday, the FDA approved the antiviral drug remdesivir (pictured) as a treatment for coronavirus patients
This is a breaking news story and will be updated.